AT
Autolus Therapeutics Ltd
🇺🇸XNAS.AUTLUnited StatesHealthcare
$1.85USDdown -0.05 (-2.63%)ClosedDelayed10:40 PM
Price$1.85-0.05 (-2.63%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US05280R1005
- CUSIP
- 05280R100
Company
- Employees
- 752
- Headquarters
- London, United States
- Website
- https://www.autolus.com
- CEO
- Dr. Christian Martin Itin Ph.D.
Market
- Shares outstanding
- 266.2M
- Market cap
- $492.4M
Highlights
- Market cap
- $503.05M
- EPS LTM
- -$1.05
- P/E LTM
- -1.55
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $117.35M+292.05%up year on year
- Net income
- -$280.03M-22.94%down year on year
- Gross margin
- 15.66%+103.09%up year on year
- Free cash flow
- -$237.45M+23.89%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.